Literature DB >> 29321315

Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling.

Maria T Sánchez-Aparicio1,2, Leighland J Feinman1,3, Adolfo García-Sastre1,2,4, Megan L Shaw5.   

Abstract

Paramyxovirus V proteins are known antagonists of the RIG-I-like receptor (RLR)-mediated interferon induction pathway, interacting with and inhibiting the RLR MDA5. We report interactions between the Nipah virus V protein and both RIG-I regulatory protein TRIM25 and RIG-I. We also observed interactions between these host proteins and the V proteins of measles virus, Sendai virus, and parainfluenza virus. These interactions are mediated by the conserved C-terminal domain of the V protein, which binds to the tandem caspase activation and recruitment domains (CARDs) of RIG-I (the region of TRIM25 ubiquitination) and to the SPRY domain of TRIM25, which mediates TRIM25 interaction with the RIG-I CARDs. Furthermore, we show that V interaction with TRIM25 and RIG-I prevents TRIM25-mediated ubiquitination of RIG-I and disrupts downstream RIG-I signaling to the mitochondrial antiviral signaling protein. This is a novel mechanism for innate immune inhibition by paramyxovirus V proteins, distinct from other known V protein functions such as MDA5 and STAT1 antagonism.IMPORTANCE The host RIG-I signaling pathway is a key early obstacle to paramyxovirus infection, as it results in rapid induction of an antiviral response. This study shows that paramyxovirus V proteins interact with and inhibit the activation of RIG-I, thereby interrupting the antiviral signaling pathway and facilitating virus replication.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  RIG-I; innate immunity; interferons; paramyxovirus

Mesh:

Substances:

Year:  2018        PMID: 29321315      PMCID: PMC5827389          DOI: 10.1128/JVI.01960-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation.

Authors:  Patricia Devaux; Veronika von Messling; Warangkhana Songsungthong; Christoph Springfeld; Roberto Cattaneo
Journal:  Virology       Date:  2006-11-16       Impact factor: 3.616

2.  The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.

Authors:  Yong Hu; Wei Li; Ting Gao; Yan Cui; Yanwen Jin; Ping Li; Qingjun Ma; Xuan Liu; Cheng Cao
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

Review 3.  Toll-like receptor and RIG-I-like receptor signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

4.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

5.  Activation of IFN-β expression by a viral mRNA through RNase L and MDA5.

Authors:  Priya Luthra; Dengyun Sun; Robert H Silverman; Biao He
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

6.  Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism.

Authors:  Michael J Ciancanelli; Valentina A Volchkova; Megan L Shaw; Viktor E Volchkov; Christopher F Basler
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

7.  Nipah virus edits its P gene at high frequency to express the V and W proteins.

Authors:  Sachin Kulkarni; Valentina Volchkova; Christopher F Basler; Peter Palese; Viktor E Volchkov; Megan L Shaw
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.

Authors:  Constantin S Friedman; Marie Anne O'Donnell; Diana Legarda-Addison; Aylwin Ng; Washington B Cárdenas; Jacob S Yount; Thomas M Moran; Christopher F Basler; Akihiko Komuro; Curt M Horvath; Ramnik Xavier; Adrian T Ting
Journal:  EMBO Rep       Date:  2008-07-18       Impact factor: 8.807

9.  Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response.

Authors:  Sébastien Plumet; Florence Herschke; Jean-Marie Bourhis; Hélène Valentin; Sonia Longhi; Denis Gerlier
Journal:  PLoS One       Date:  2007-03-14       Impact factor: 3.240

10.  Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways.

Authors:  Megan L Shaw; Washington B Cardenas; Dmitriy Zamarin; Peter Palese; Christopher F Basler
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

View more
  29 in total

1.  The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.

Authors:  Jorge Vera-Otarola; Loretto Solis; Fernando Lowy; Valeria Olguín; Jenniffer Angulo; Karla Pino; Nicole D Tischler; Carola Otth; Paula Padula; Marcelo López-Lastra
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  The influenza NS1 protein modulates RIG-I activation via a strain-specific direct interaction with the second CARD of RIG-I.

Authors:  Alexander S Jureka; Alex B Kleinpeter; Jennifer L Tipper; Kevin S Harrod; Chad M Petit
Journal:  J Biol Chem       Date:  2019-12-16       Impact factor: 5.157

Review 3.  Mechanisms of Non-segmented Negative Sense RNA Viral Antagonism of Host RIG-I-Like Receptors.

Authors:  Daisy W Leung
Journal:  J Mol Biol       Date:  2019-06-14       Impact factor: 5.469

4.  To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.

Authors:  Adam Hage; Ricardo Rajsbaum
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

5.  Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly.

Authors:  Takayuki Komatsu; Yukie Tanaka; Yoshinori Kitagawa; Naoki Koide; Yoshikazu Naiki; Naoko Morita; Bin Gotoh; Takashi Yokochi
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

Review 6.  Henipavirus infection of the central nervous system.

Authors:  Brian E Dawes; Alexander N Freiberg
Journal:  Pathog Dis       Date:  2019-03-01       Impact factor: 3.166

Review 7.  Type I and Type II Interferon Antagonism Strategies Used by Paramyxoviridae: Previous and New Discoveries, in Comparison.

Authors:  Giuseppe Pisanelli; Ugo Pagnini; Giuseppe Iovane; Adolfo García-Sastre
Journal:  Viruses       Date:  2022-05-21       Impact factor: 5.818

8.  Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.

Authors:  Chi-You Chang; Helene Minyi Liu; Ming-Fu Chang; Shin C Chang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 9.  TRIM Proteins in Host Defense and Viral Pathogenesis.

Authors:  Maria I Giraldo; Adam Hage; Sarah van Tol; Ricardo Rajsbaum
Journal:  Curr Clin Microbiol Rep       Date:  2020-08-08

Review 10.  Camouflage and interception: how pathogens evade detection by intracellular nucleic acid sensors.

Authors:  Leonie Unterholzner; Jessica F Almine
Journal:  Immunology       Date:  2018-12-18       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.